Extendicare stock closed at CA$32.44 after a rough few weeks, with the share price down about 12% over the past month, yet the latest earnings tell a more supportive story. Q2 revenue landed at CA$611.0m, helped by the CBI Health acquisition and broader home care growth, while adjusted funds from operations per share climbed strongly to CA$0.448.
The short term looks choppy on the screen, but for long term investors the bigger question is whether this step change in scale and cash generation in a capacity constrained elder care sector can justify today’s multiple and the extra balance sheet risk.
Like the jump in Extendicare's cash generation but uneasy about the added balance sheet risk that comes with it? Check out our curated list of list of solid balance sheet and fundamentals stocks (11 results).
Tired of scrolling through long earnings tables and raw figures to make sense of Extendicare? Get a clear visual read on Extendicare's cash generation and valuation in our full company report for Extendicare.
For investors focused on Extendicare’s defensive, needs based role in senior care, the latest numbers broadly back that angle. Revenue rose 59% to CA$611.0m on acquisitions and home care expansion, while adjusted EBITDA grew 71% to CA$68.3m. AFFO per share climbed to CA$0.448, up about 53%, which supports the idea of a larger, more cash generative platform. Long term care margins improved and the balance sheet sits around 2.5x net debt to EBITDA with investment grade unsecured debt. This fits a cautious but constructive income and stability narrative.
The results also give some weight to the cautious view around Extendicare. Basic EPS fell about 14% year on year despite stronger cash metrics, held back by financing and integration costs plus director related payroll taxes. Home health care margins compressed by roughly 60 bps as labour and technology investments picked up while Ontario rates did not rise. Recent labour unrest at long term care sites and ongoing integration of CBI and Closing the Gap show execution and staffing risks remain very real, even with a more flexible unsecured capital structure.
Review whether labour unrest, insider selling and higher debt are isolated or structural by scanning our latest risk analysis for Extendicare which shows 2 important warning signs.If Extendicare's mix of stronger cash metrics and real labour and balance sheet risks has your attention, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value and watch for a more attractive entry point. After you own the stock, use the Portfolio Command Center to cut through market noise and focus on the key earnings, balance sheet and risk updates that matter most to your thesis. For a longer term view, plug into the Community to see how other investors are thinking about the same issues you are weighing. By spotting hidden catalysts and risks early, you give yourself a better chance of staying ahead of the market.
Some stocks move first, others follow. Spot fresh ideas with real momentum before they get caught by the crowd and the easy edge drops away. Act now.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com